Buy Seattle Genetics Stock | SGEN Stock Price & Latest News | Public
SGEN

Seattle Genetics

$0.00 (0.00%)Today

    About SGEN

    Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for soli...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.15
    -0.23
    -0.61
    -0.98
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.46

    Actual EPS
    Q3 2020

    Stats

    Market Cap$30,42B
    Volume52,29k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$187.99
    1 Year Low$71.70
    Open$173.57
    High$176.31
    Low$172.80

    Buy any stock with any amount of money.

    Download the App
    Download the app